{
  "ptid_time": "037_S_4706_2012-05-10",
  "img_path": "/data/qiuhui/data/adni/images/037_S_4706/2012-05-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 18,014 mm³, 40.0% below the reference mean. With a Z-score of -0.95 (17.1th percentile), this represents normal volume ; hippocampal volume measures 7,731 mm³, 3.7% below the reference mean. With a Z-score of -0.37 (35.6th percentile), this represents normal volume ; whole brain volume measures 1,091,810 mm³, 3.8% below the reference mean. With a Z-score of -0.53 (29.7th percentile), this represents normal volume ; entorhinal cortex volume measures 4,081 mm³, 4.3% below the reference mean. With a Z-score of -0.30 (38.4th percentile), this represents normal volume ; fusiform gyrus volume measures 19,723 mm³, 0.9% below the reference mean. With a Z-score of -0.08 (46.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,310 mm³, 0.5% below the reference mean. With a Z-score of -0.04 (48.5th percentile), this represents normal volume . ",
  "text_data": "Age is 60.7 years. Gender is Male. Education: 14 years. Handedness: Right. Race: White. Medical history: Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Renal-Genitourinary; Major Surgical Procedures. MMSE: 30.0. MoCA: 19.0. Logical Memory: 8.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 0.93 SUVR (mild reduced); Total tau: 261.30 pg/mL (normal ); Phosphorylated tau: 23.94 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements (hippocampus, entorhinal cortex, fusiform gyrus, etc.) are all within normal ranges (Z-scores close to 0, percentiles near 50th). However, the MoCA score of 19 is below the typical cutoff for normal cognition (≥26), suggesting cognitive impairment despite normal structural imaging and biomarkers (normal tau, mild AV45 reduction).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (MoCA is concerning, but structural and CSF biomarkers do not strongly support neurodegeneration; APOE4 carrier status increases risk but is not diagnostic).  \n\n*Note: The discrepancy between MMSE (30, normal) and MoCA (19, impaired) warrants further clinical correlation—possible non-Alzheimer’s etiology (e.g., vascular, Lewy body) or testing confounders (education, language, attention).*",
  "timestamp": "2025-07-26T06:47:03.547605"
}